April 29 (SeeNews) - Bosnia’s biggest pharmaceutical company, Bosnalijek, said on Wednesday it expects a 5.0% rise in its sales revenue to 113 million marka ($76 million/58 million euro) in 2009 after posting sales of 23.9 million marka in the first quarter of the year.